Literature DB >> 12113493

Assessment of varicella underreporting in Italy.

M L Ciofi degli Atti1, M C Rota, D Mandolini, A Bella, G Gabutti, P Crovari, S Salmaso.   

Abstract

We conducted a study to assess the degree of varicella underreporting in Italy, and its distribution by age group and geographical area. Underreporting in individuals from 6 months to 20 years of age was computed as the ratio between the varicella seroprevalence in 1996 and the 1996 lifetime cumulative incidence based on statutory notifications. The degree of underreporting at the national level was 7.7 (95% CI 7.4-7.9); underreporting was greater in older age groups and in southern Italy. Quantification of underreporting can contribute to better understanding of the burden of varicella and to evaluating the potential impact of mass vaccination.

Mesh:

Year:  2002        PMID: 12113493      PMCID: PMC2869845          DOI: 10.1017/s0950268802006878

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  15 in total

1.  Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades.

Authors:  A Bechini; M Chellini; E Pellegrino; E Tiscione; C Lorini; G Bonaccorsi; P Bonanni; S Boccalini
Journal:  J Prev Med Hyg       Date:  2018-06-01

2.  Underreporting of congenital rubella in Italy, 2010-2014.

Authors:  Cristina Giambi; Antonino Bella; Antonietta Filia; Martina Del Manso; Gloria Nacca; Silvia Declich; Maria Cristina Rota
Journal:  Eur J Pediatr       Date:  2017-05-28       Impact factor: 3.183

3.  Varicella vaccination in Europe: are we ready for a universal childhood programme?

Authors:  Nitu Sengupta; Robert Booy; H J Schmitt; Heikki Peltola; Pierre Van-Damme; R Fabian Schumacher; Magda Campins; Carlos Rodrigo; Terho Heikkinen; Jane Seward; Aisha Jumaan; Adam Finn; Per Olcén; Nancy Thiry; Catherine Weil-Olivier; Judith Breuer
Journal:  Eur J Pediatr       Date:  2007-03-03       Impact factor: 3.860

4.  The pre-vaccination regional epidemiological landscape of measles in Italy: contact patterns, effort needed for eradication, and comparison with other regions of Europe.

Authors:  Piero Manfredi; Eugene M Cleur; John R Williams; Stefania Salmaso; Marta Ciofi Degli Atti
Journal:  Popul Health Metr       Date:  2005-02-17

Review 5.  A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data.

Authors:  K Bollaerts; M Riera-Montes; U Heininger; N Hens; A Souverain; T Verstraeten; S Hartwig
Journal:  Epidemiol Infect       Date:  2017-08-22       Impact factor: 2.451

6.  Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Authors:  Margarita Riera-Montes; Kaatje Bollaerts; Ulrich Heininger; Niel Hens; Giovanni Gabutti; Angel Gil; Bayad Nozad; Grazina Mirinaviciute; Elmira Flem; Audrey Souverain; Thomas Verstraeten; Susanne Hartwig
Journal:  BMC Infect Dis       Date:  2017-05-18       Impact factor: 3.090

7.  The epidemiology of Varicella Zoster Virus infection in Italy.

Authors:  Giovanni Gabutti; Maria C Rota; Marcello Guido; Antonella De Donno; Antonino Bella; Marta L Ciofi degli Atti; Pietro Crovari
Journal:  BMC Public Health       Date:  2008-10-27       Impact factor: 3.295

8.  Trends of human brucellosis in Italy, 1998-2010.

Authors:  F R Mancini; A Bella; C Graziani; C Marianelli; L Mughini-Gras; P Pasquali; M G Pompa; C Rizzo; E Rizzuto; L Busani
Journal:  Epidemiol Infect       Date:  2013-09-18       Impact factor: 4.434

9.  Heterogeneity in regional notification patterns and its impact on aggregate national case notification data: the example of measles in Italy.

Authors:  John R Williams; Piero Manfredi; Alisa R Butler; Marta Ciofi Degli Atti; Stefania Salmaso
Journal:  BMC Public Health       Date:  2003-07-18       Impact factor: 3.295

10.  Impact of universal vaccination against varicella in Italy.

Authors:  Angela Bechini; Sara Boccalini; Vincenzo Baldo; Silvia Cocchio; Paolo Castiglia; Tolinda Gallo; Sandro Giuffrida; Francesco Locuratolo; Silvio Tafuri; Domenico Martinelli; Rosa Prato; Emanuele Amodio; Francesco Vitale; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.